RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Rituximab and gemcitabine are associated with acute exacerbation of chronic hepatitis C virus infection in patients with cancer

Torres, HA., Mahale, P., Ying, J., & Kontoyiannis, DP. (2011). Rituximab and gemcitabine are associated with acute exacerbation of chronic hepatitis C virus infection in patients with cancer. Hepatology, 54, 1177A-1178A.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.